Ting-Pau Oei has been the CEO and Co-Chairman of xMD Diagnostics, Inc.since 2017. He is an accomplished healthcare professional and entrepreneur with a 30+ year track record of successful healthcare general management, operating and investing experience. His career is unique, having been a venture capitalist at both a strategic corporate (Johnson & Johnson Development Corporation) and independent venture capital firms (Gore Range Capital, Easton Capital and L Capital Partners) prior to joining xMD Diagnostics, Inc.
Mr. Oei spent a total of 22 years at Johnson & Johnson, the last 12 years as Vice President at Johnson & Johnson Development Corporation (JJDC), J&J's longstanding venture capital arm. Mr. Oei was responsible for the firm's biotech, diagnostics and digital health investments which included a broad range of companies from early-stage startups to developmental/growth stage and public companies. He has invested in over 60 life sciences companies, served on the board of directors of over 25 private venture backed companies, many of whom have been acquired or gone public. In addition to his extensive venture capital investing experience, Mr. Oei has broad prior experience as an operating executive including business development, M&A, marketing & sales.
Mr. Oei received his undergraduate degree in economics from Union College (N.Y.) and MBA from Columbia Business School.
tingpau@xMDDiagnostics.com
Ting-Pau Oei has been the CEO and Co-Chairman of xMD Diagnostics, Inc. since 2017. He is an accomplished healthcare professional and entrepreneur with a 30+ year track record of successful healthcare general management, operating and investing experience. His career is unique, having been a venture capitalist at both a strategic corporate (Johnson & Johnson Development Corporation) and independent venture capital firms (Gore Range Capital, Easton Capital and L Capital Partners) prior to joining xMD Diagnostics, Inc.
Mr. Oei spent a total of 22 years at Johnson & Johnson, the last 12 years as Vice President at Johnson & Johnson Development Corporation (JJDC), J&J's longstanding venture capital arm. Mr. Oei was responsible for the firm's biotech, diagnostics and digital health investments which included a broad range of companies from early-stage startups to developmental/growth stage and public companies. He has invested in over 60 life sciences companies, served on the board of directors of over 25 private venture backed companies, many of whom have been acquired or gone public. In addition to his extensive venture capital investing experience, Mr. Oei has broad prior experience as an operating executive including business development, M&A, marketing & sales.
Mr. Oei received his undergraduate degree in economics from Union College (N.Y.) and MBA from Columbia Business School.